Align Technology, Inc. (0HCK.L)
USD 221.79
(-3.78%)
USD 221.79
(-3.78%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.08 Billion USD | 2.29% |
| 2022 | 5.94 Billion USD | 0.1% |
| 2021 | 5.94 Billion USD | 23.03% |
| 2020 | 4.82 Billion USD | 93.13% |
| 2019 | 2.5 Billion USD | 21.84% |
| 2018 | 2.05 Billion USD | 15.05% |
| 2017 | 1.78 Billion USD | 27.78% |
| 2016 | 1.39 Billion USD | 20.5% |
| 2015 | 1.15 Billion USD | 17.27% |
| 2014 | 987.99 Million USD | 18.73% |
| 2013 | 832.14 Million USD | 10.03% |
| 2012 | 756.31 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 6.15 Billion USD | 1.18% |
| 2024 Q3 | 6.36 Billion USD | 3.37% |
| 2024 Q2 | 6.15 Billion USD | 0.04% |
| 2023 Q2 | 6.14 Billion USD | 4.12% |
| 2023 Q1 | 5.9 Billion USD | -0.78% |
| 2023 FY | 6.08 Billion USD | 2.29% |
| 2023 Q4 | 6.08 Billion USD | -3.71% |
| 2023 Q3 | 6.31 Billion USD | 2.83% |
| 2022 Q3 | 5.91 Billion USD | 1.77% |
| 2022 Q2 | 5.81 Billion USD | -2.24% |
| 2022 Q1 | 5.94 Billion USD | 0.02% |
| 2022 FY | 5.94 Billion USD | 0.1% |
| 2022 Q4 | 5.94 Billion USD | 0.59% |
| 2021 Q1 | 5.06 Billion USD | 4.97% |
| 2021 FY | 5.94 Billion USD | 23.03% |
| 2021 Q4 | 5.94 Billion USD | 5.17% |
| 2021 Q3 | 5.65 Billion USD | 4.72% |
| 2021 Q2 | 5.39 Billion USD | 6.43% |
| 2020 Q4 | 4.82 Billion USD | 9.39% |
| 2020 Q1 | 3.96 Billion USD | 58.55% |
| 2020 Q3 | 4.41 Billion USD | 9.67% |
| 2020 Q2 | 4.02 Billion USD | 1.54% |
| 2020 FY | 4.82 Billion USD | 93.13% |
| 2019 Q1 | 2.23 Billion USD | 8.87% |
| 2019 FY | 2.5 Billion USD | 21.84% |
| 2019 Q4 | 2.5 Billion USD | 6.4% |
| 2019 Q3 | 2.35 Billion USD | 0.19% |
| 2019 Q2 | 2.34 Billion USD | 4.99% |
| 2018 Q2 | 1.91 Billion USD | 7.51% |
| 2018 Q3 | 1.92 Billion USD | 0.62% |
| 2018 Q4 | 2.05 Billion USD | 6.43% |
| 2018 FY | 2.05 Billion USD | 15.05% |
| 2018 Q1 | 1.78 Billion USD | -0.07% |
| 2017 Q1 | 1.45 Billion USD | 4.52% |
| 2017 FY | 1.78 Billion USD | 27.78% |
| 2017 Q4 | 1.78 Billion USD | 5.09% |
| 2017 Q3 | 1.69 Billion USD | 9.44% |
| 2017 Q2 | 1.55 Billion USD | 6.3% |
| 2016 Q4 | 1.39 Billion USD | 2.74% |
| 2016 FY | 1.39 Billion USD | 20.5% |
| 2016 Q3 | 1.35 Billion USD | 8.6% |
| 2016 Q2 | 1.25 Billion USD | 3.62% |
| 2016 Q1 | 1.2 Billion USD | 4.22% |
| 2015 FY | 1.15 Billion USD | 17.27% |
| 2015 Q4 | 1.15 Billion USD | 7.32% |
| 2015 Q3 | 1.07 Billion USD | 4.96% |
| 2015 Q2 | 1.02 Billion USD | 0.02% |
| 2015 Q1 | 1.02 Billion USD | 4.09% |
| 2014 Q1 | 885.64 Million USD | 6.43% |
| 2014 Q4 | 987.99 Million USD | 4.19% |
| 2014 FY | 987.99 Million USD | 18.73% |
| 2014 Q3 | 948.28 Million USD | 7.1% |
| 2014 Q2 | 885.43 Million USD | -0.02% |
| 2013 FY | 832.14 Million USD | 10.03% |
| 2013 Q3 | 759.2 Million USD | 7.86% |
| 2013 Q4 | 832.14 Million USD | 9.61% |
| 2013 Q1 | 726.24 Million USD | -3.98% |
| 2013 Q2 | 703.89 Million USD | -3.08% |
| 2012 Q4 | 756.31 Million USD | 0.0% |
| 2012 FY | 756.31 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -1539.483% |
| Accuray Incorporated | 468.62 Million USD | -1198.234% |
| Elevance Health Inc. | 108.92 Billion USD | 94.415% |
| AxoGen, Inc. | 196.82 Million USD | -2990.977% |
| Boston Scientific Corporation | 35.13 Billion USD | 82.685% |
| CVS Health Corporation | 249.72 Billion USD | 97.564% |
| Cardinal Health, Inc. | 45.12 Billion USD | 86.517% |
| Centene Corporation | 84.64 Billion USD | 92.812% |
| DaVita Inc. | 17.61 Billion USD | 65.471% |
| HCA Healthcare, Inc. | 56.21 Billion USD | 89.177% |
| Hologic, Inc. | 9.15 Billion USD | 33.553% |
| Humana Inc. | 47.06 Billion USD | 87.073% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -86.626% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | 63.624% |
| Masimo Corporation | 3.04 Billion USD | -100.029% |
| McKesson Corporation | 67.44 Billion USD | 90.979% |
| Patterson Companies, Inc. | 2.96 Billion USD | -104.909% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | 56.612% |
| ResMed Inc. | 6.87 Billion USD | 11.474% |
| Henry Schein, Inc. | 10.57 Billion USD | 42.458% |
| Teladoc Health, Inc. | 4.39 Billion USD | -38.51% |
| Universal Health Services, Inc. | 14.35 Billion USD | 57.624% |
| Veeva Systems Inc. | 5.91 Billion USD | -2.926% |
| Baxter International Inc. | 28.27 Billion USD | 78.484% |
| Becton, Dickinson and Company | 52.78 Billion USD | 88.473% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 60.6% |
| Danaher Corporation | 84.48 Billion USD | 92.799% |
| Stryker Corporation | 39.91 Billion USD | 84.757% |
| Medtronic plc | 89.98 Billion USD | 93.239% |